Strides in cancer research, NIH consulting, and Lynx | GenomeWeb

One year ago this month, Genome Technology’s cover story attacked cancer from a handful of systems biology standpoints, from bioinformatics to RNAi. We spoke with Colin Hill, co-founder of Gene Network Sciences, who introduced us to his company’s approaches to modeling the mechanisms of cancer drugs. These days, the biosimulation firm’s technology is being used to classify patient subgroups and identify biomarkers in clinical settings thanks to a partnership with the Mary Crowley Medical Research Center.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Nucleic Acids Research this week: ProTraits includes genetic, phenotypic data on bacteria, archaea; Candida albicans assembly 22; and more.

The Wall Street Journal reports that researchers are looking beyond Cas9 for CRISPR editing.

Familial DNA searches in criminal cases are winning over some critics, the Los Angeles Times reports.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.